Skip to content
Screener

Seres Therapeutics MCRB Q2 2025 earnings

Reported August 6, 2025 · Before market open

EPS-$2.27Beat by $0.45
Revenue estimate$5.9M
EPS estimate-$2.72

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$6.4M
EPS estimate-$1.01

FAQ

When did Seres Therapeutics report Q2 2025 earnings?
Seres Therapeutics (MCRB) reported Q2 2025 earnings on August 6, 2025 before market open.
What were Seres Therapeutics's Q2 2025 revenue and EPS?
Seres Therapeutics reported eps of $-2.27 for Q2 2025.
Did Seres Therapeutics beat estimates in Q2 2025?
EPS beat the consensus estimate of $-2.72 by $0.45.
How did Seres Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 48.4% from $-4.40.
Where can I find Seres Therapeutics's Q2 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-173985) and the 10-Q periodic report (0000950170-25-103611) directly on SEC EDGAR. The filing index links above go to sec.gov.